Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TFINE: Docetaxel Maintenance in Advanced NSCLC
NCT01038661Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2009
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in non-small cell lung cancer (NSCLC), sponsored by Sanofi. Started Nov 2009; status: completed.
02
Drugs
docetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01038661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01038661.